Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
101 - 125 out of 509Page size: 25
  1. 2023
  2. Published

    The association between blood oxygen saturation and baroreflex sensitivity in adults with type 1 diabetes with and without albuminuria

    Laursen, J. C., Hansen, C. S., Bordino, M., Frimodt-Møller, M., Hansen, T. W., Bernardi, L., Groop, P. H. & Rossing, Peter, 2023, In: Journal of Diabetes and its Complications. 37, 6, 6 p., 108473.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The effect of diabetes and the diabetogenic TBC1D4 p.Arg684ter variant on kidney function in Inuit in Greenland

    Overvad, M., Díaz, L. J., Bjerregaard, P., Pedersen, M. L., Larsen, C. V. L., Grarup, Niels, Hansen, Torben, Rossing, Peter & Jørgensen, M. E., 2023, In: International Journal of Circumpolar Health. 82, 8 p., 2191406.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2888-2896 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

    Rossing, Peter, Anker, S. D., Filippatos, G., Pitt, B., Ruilope, L. M., Billings, L. K., Green, J. B., Koya, D., Mosenzon, O., Pantalone, K. M., Ahlers, C., Lage, A., Lawatscheck, R., Scalise, A. & Bakris, G. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2989-2998 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease

    on behalf of the FLOW Steering Committee and FLOW Trial Investigators, O. B. O. T. F. S. C. A. F. T. I., 2023, In: Nephrology Dialysis Transplantation. 38, 9, p. 2041-2051 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study

    Stougaard, E. B., Amadid, H., Søndergaard, E., Carstensen, Bendix, Jørgensen, M. E., Nørgaard, Kirsten, Rossing, Peter, Persson, F. & Vistisen, D., 2023, In: Diabetes Care. 46, 11, p. 1897-1902 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study

    Tougaard, N. H., Hansen, T. W. & Rossing, Peter, 2023, In: Journal of Diabetes and its Complications. 37, 10, 6 p., 108611.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. 2022
  10. Published

    Endotrophin as a Marker of Complications in a Type 2 Diabetes Cohort

    Tougaard, N. H., Møller, A. L., Rønn, P. F., Hansen, T. W., Genovese, F., Karsdal, M. A., Rasmussen, D. G. K. & Rossing, Peter, Nov 2022, In: Diabetes Care. 45, 11, p. 2746-2748 3 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials

    Zobel, E. H., von Scholten, B. J., Hansen, T. W., Persson, F., Rasmussen, S., Wolthers, B. & Rossing, Peter, Feb 2022, In: Diabetes, Obesity and Metabolism. 24, 2, p. 281-288 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    16-LB: Effects of Finerenone in Patients with CKD and T2D Are Independent of HbA1c at Baseline, HbA1c Variability, and Duration of Diabetes

    Mcgill, J. B., Agarwal, R., Anker, S., Bakris, G., Filippatos, G., Pitt, B., Ruilope, L. M., Birkenfeld, A. L., Caramori, L., Brinker, M. D., Joseph, A., Lage, A. Z., Lawatscheck, R., Scott, C. & Rossing, Peter, 2022, In: Diabetes. 71, Supplement_1, 16-LB.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  13. Published

    A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

    Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2022, In: Kidney International. 101, 1, p. 174-184 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Acute and Long-Term Treatment With Dapagliflozin and Association With Serum Soluble Urokinase Plasminogen Activator Receptor

    Rotbain Curovic, V., Houlind, Morten Baltzer, Hansen, T. W., Eugen-Olsen, J., Laursen, J. C., Eickhoff, M. K., Persson, F. & Rossing, Peter, 2022, In: Frontiers in Pharmacology. 13, 799915.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    Association between plasma apolipoprotein M and cardiac autonomic neuropathy in type 1 diabetes

    Safi, M., Borup, A., Stevns Hansen, C., Rossing, Peter, Thorsten Jensen, M. & Christoffersen, Christina, 2022, In: Diabetes Research and Clinical Practice. 189, 7 p., 109943.

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Published

    Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis

    Pitt, B., Agarwal, R., Anker, S. D., Ruilope, L. M., Rossing, Peter, Ahlers, C., Brinker, M., Joseph, A., Lambelet, M., Lawatscheck, R. & Filippatos, G. S., 2022, In: JAMA network open. 5, 10, 10 p., E2236123.

    Research output: Contribution to journal › Journal article › Research › peer-review

  17. Published

    Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study

    Curovic, V. R., Roy, N., Hansen, T. W., Caramori, M. L., Cherney, D. Z., Boer, I. H. D., Emanuele, M. A., Hirsch, I. B., Lingvay, I., Mcgill, J. B., Polsky, S., Pop-Busui, R., Sigal, R. J., Tuttle, K. R., Umpierrez, G. E., Wallia, A., Rosas, S. E. & Rossing, Peter, 2022, In: Diabetes Research and Clinical Practice. 193, 8 p., 110119.

    Research output: Contribution to journal › Journal article › Research › peer-review

  18. Published

    Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

    Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G., Pitt, B., Rossing, Peter, Sarafidis, P., Schmieder, R. E., Joseph, A., Rethemeier, N., Nowack, C., Bakris, G. L. & the FIDELIO-DKD Investigators, T. F. I., 2022, In: Hypertension. 79, 12, p. 2685-2695 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  19. Published

    Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Is Associated With Disturbances in TCA, Lipid, and Glucose Metabolism

    Hansen, C. S., Suvitaival, T., Theilade, Karen Simone, Mattila, I., Lajer, M., Trošt, K., Ahonen, L., Hansen, T. W., Legido-Quigley, C., Rossing, Peter & Ahluwalia, Tarun Veer Singh, 2022, In: Frontiers in Endocrinology. 13, 831793.

    Research output: Contribution to journal › Journal article › Research › peer-review

  20. Published

    Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: The FIDELITY pooled analysis

    Agarwal, R., Filippatos, G., Pitt, B., Anker, S. D., Rossing, Peter, Joseph, A., Kolkhof, P., Nowack, C., Gebel, M., Ruilope, L. M. & Bakris, G. L., 2022, In: European Heart Journal. 43, 6, p. 474-484 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  21. Published

    Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes

    Ferreira-Divino, L. F., Suvitaival, T., Curovic, V. R., Tofte, N., Trošt, K., Mattila, I. M., Theilade, Karen Simone, Winther, S. A., Hansen, T. W., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, Peter, 2022, In: Cardiovascular Diabetology. 21, 10 p., 135.

    Research output: Contribution to journal › Journal article › Research › peer-review

  22. Published

    Clinical perspective—evolving evidence of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes

    Rossing, Peter, 2022, In: Kidney International Supplements. 12, 1, p. 27-35 9 p.

    Research output: Contribution to journal › Review › Research › peer-review

  23. Published

    Copeptin and renal function decline, cardiovascular events and mortality in type 1 diabetes

    Heinrich, N. S., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, Tarun Veer Singh, Jeppesen, J. L., Persson, F., Hansen, T. W., Goetze, Jens P. & Rossing, Peter, 2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 1, p. 100–107

    Research output: Contribution to journal › Journal article › Research › peer-review

  24. Published

    Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD

    the DAPA-CKD Trial Committees and Investigators, T. D. T. C. A. I., 2022, In: Journal of the American Society of Nephrology. 33, 11, p. 2094-2107 14 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  25. Published

    Dapagliflozin Improves the Urinary Proteomic Kidney-Risk Classifier CKD273 in Type 2 Diabetes with Albuminuria: A Randomized Clinical Trial

    Curovic, V. R., Eickhoff, M. K., Rönkkä, T., Frimodt-Møller, M., Hansen, T. W., Mischak, H., Rossing, Peter, Ahluwalia, Tarun Veer Singh & Persson, F., 2022, In: Diabetes Care. 45, 11, p. 2662-2668 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  26. Published

    Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Rossing, P., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P., Sabatine, M. S., Solomon, S. D., DeMets, D. L., Bengtsson, O., Lindberg, M., Langkilde, A. M., Sjöstrand, M., Stefansson, B. V., Karlsson, C., Chertow, G. M. & 7 others, Hou, F. F., Correa-Rotter, R., Toto, R. D., Wheeler, D. C., McMurray, J. J. V., Heerspink, H. J. L. & DAPA-CKD and DAPA-HF Trial Committees and Investigators, D. A. D. T. C. A. I., 2022, In: The Lancet Diabetes and Endocrinology. 10, 1, p. 24-34 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  27. Published

    Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)

    de Boer, I. H., Khunti, K., Sadusky, T., Tuttle, K. R., Neumiller, J. J., Rhee, C. M., Rosas, S. E., Rossing, Peter & Bakris, G., 2022, In: Diabetes Care. 45, 12, p. 3075-3090

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 12937790